Methoxyarachidonoyl Fluorophosphonate

Methoxyarachidonoyl Fluorophosphonate

SCHEMBL22222736

CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCP(=O)(F)OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 1.00
MEN1 O00255 2/20 1.00
ALDH1A1 P00352 2/20 1.00
MAPT P10636 2/20 1.00
KMT2A Q03164 2/20 1.00
PLA2G4A P47712 1/20 1.00
PAFAH1B2 P68402 1/20 1.00
MGLL Q99685 1/20 1.00
ABHD6 Q9BV23 1/20 1.00
TRPV1 Q8NER1 1/20 0.49
PPARG P37231 3/20 0.45
FFAR1 O14842 2/20 0.45
PPARD Q03181 2/20 0.45
PPARA Q07869 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
KDM4E B2RXH2 1/20 0.45
USP2 O75604 1/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
CYP3A4 P08684 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methoxyarachidonoyl Fluorophosphonate SCHEMBL8253710 1.00 FAAH (1.00) FAAHMEN1ALDH1A1MAPTKMT2A
Methoxyarachidonoyl Fluorophosphonate SCHEMBL19877180 1.00 FAAH (1.00) FAAHMEN1ALDH1A1MAPTKMT2A
SCHEMBL20971528 0.97 FAAH (0.94) FAAHMEN1ALDH1A1MAPTKMT2A
SCHEMBL23617058 0.89 ALDH1A1 (0.79) FAAHMEN1ALDH1A1MAPTKMT2A
SCHEMBL4271998 0.79 ALDH1A1 (0.66) FAAHMEN1ALDH1A1MAPTKMT2A
SCHEMBL4271993 0.79 ALDH1A1 (0.66) FAAHMEN1ALDH1A1MAPTKMT2A
SCHEMBL458863 0.78 MEN1 (0.63) FAAHMEN1ALDH1A1MAPTKMT2A
SCHEMBL177496 0.78 MEN1 (0.63) FAAHMEN1ALDH1A1MAPTKMT2A
SCHEMBL18437601 0.77 FAAH (0.62) FAAHMEN1ALDH1A1MAPTKMT2A
SCHEMBL1887711 0.76 MEN1 (0.61) FAAHMEN1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117357648-B Application of arachidonic acid inhibitor in improving tumor immunity microenvironment 中国科学技术大学 2026-05-12 CN disclosed
EP-4731764-A2 DOUBLE STRANDED RNA TARGETING PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) AND METHODS OF USE THEREOF Sanegene Bio USA Inc. (US) 2026-04-29 EP disclosed
CN-120058944-A Anti-GAL 3 antibodies and uses thereof 真和制药有限公司 2025-05-30 CN disclosed
US-20250104806-A1 Detecting Cross-Contamination In Cell-Free RNA GRAIL, LLC 2025-03-27 US disclosed
CN-113711036-B Anti-GAL 3 antibodies and uses thereof 真和制药有限公司 2025-03-18 CN disclosed
CN-119633105-A DC vaccine and preparation method and application thereof 嘉庚创新实验室 2025-03-18 CN disclosed
WO-2024263915-A2 DOUBLE STRANDED RNA TARGETING PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) AND METHODS OF USE THEREOF SANEGENE BIO USA INC. (US) 2024-12-26 WO disclosed
EP-4469596-A1 DETECTING CROSS-CONTAMINATION IN CELL-FREE RNA Grail, Inc. (US) 2024-12-04 EP disclosed
CN-115918526-B Haploid inducer composition and methods of use thereof 先正达参股股份有限公司 2024-11-12 CN disclosed
CN-116063505-B Anti-GAL 3 antibodies and uses thereof 真和制药有限公司 2024-05-03 CN disclosed
EP-3681504-B1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ICAGEN INC (US) 2023-08-23 EP disclosed
WO-2023147509-A1 DETECTING CROSS-CONTAMINATION IN CELL-FREE RNA GRAIL, LLC (US) 2023-08-03 WO disclosed
CN-116063505-A anti-GAL 3 antibodies and uses thereof 真和制药有限公司 2023-05-05 CN disclosed
CN-116063520-A anti-GAL 3 antibodies and uses thereof 真和制药有限公司 2023-05-05 CN disclosed
CN-115918526-A Haploid inducer compositions and methods of use thereof 先正达参股股份有限公司 2023-04-07 CN disclosed
US-11573224-B2 Methods of detection using X-ray fluorescence ICAGEN, LLC (US) 2023-02-07 US disclosed
CN-114478791-A Constructs targeting AFP peptide/MHC complexes and uses thereof 优瑞科生物技术公司 2022-05-13 CN disclosed
CN-114456272-A Constructs targeting AFP peptide/MHC complexes and uses thereof 优瑞科生物技术公司 2022-05-10 CN disclosed
EP-3845061-A1 HAPLOID INDUCTION COMPOSITIONS AND METHODS FOR USE THEREFOR Syngenta Participations AG (CH) 2021-07-07 EP disclosed
WO-2020144192-A1 USE OF ARACHIDONYL TRIFLUOROMETHYL KETONE MOSAIQUES DIAGNOSTICS UND THERAPEUTICS AG (DE) 2020-07-16 WO disclosed